|
|
||||||||
Experimental Studies |
1 From the Department of Radiology, Division of Ultrasound, Thomas Jefferson University Hospital, Suite 763J, Main Bldg, 132 S 10th St, Philadelphia, PA 19107. Received November 10, 2000; revision requested December 24; final revision received August 9, 2001; accepted September 5. Supported in part by Nycomed Amersham, Oslo, Norway, and Siemens Medical Systems, Issaquah, Wash. Address correspondence to F.F. (e-mail: forsberg@esther.rad.tju.edu).
PURPOSE: To compare conventional ultrasonography (US) and magnetic resonance (MR) imaging with contrast agentenhanced US for detection of VX-2 liver tumors in rabbits.
MATERIALS AND METHODS: Conventional gray-scale liver US was performed in 65 rabbits, 38 of which had VX-2 hepatic tumor implants. Twenty minutes after contrast agent injection, gray-scale pulse-inversion harmonic US images of the liver-specific phase were obtained. Following sacrifice of the animals, T1- and T2-weighted MR imaging was performed at 4-mm intervals. Pathologic analysis was performed as the reference standard. The capability of each imaging modality to correctly depict tumor presence or absence and the number of tumors was compared.
RESULTS: Conventional US correctly depicted the presence or absence of tumors in 54 rabbits, for an accuracy of 83%, sensitivity of 71%, and specificity of 100%. With contrast-enhanced US, accuracy increased to 92% (60 correct cases); sensitivity, to 87%; and specificity, to 100%. MR imaging facilitated 56 correct diagnoses, for an accuracy of 86%, sensitivity of 82%, and specificity of 93%. There was a marginally significant difference between US with and US without contrast agent (P = .07) but not between MR imaging and contrast-enhanced US (P
.34). When the numbers of correctly detected tumors were compared, contrast-enhanced US performed significantly better than MR imaging (P = .02) and conventional US (P = .04).
CONCLUSION: There was no significant difference between contrast-enhanced US and MR imaging in the detection of hepatic tumors, whereas contrast-enhanced US had the highest accuracy (92%) of the three modalities studied.
© RSNA, 2002
Index terms: Animals Liver neoplasms, 761.32 Liver neoplasms, MR, 761.121411, 761.121415 Liver neoplasms, US, 761.12988, 761.12989 Ultrasound (US), harmonic study, 761.12988, 761.12989
This article has been cited by other articles:
![]() |
F. Moriyasu and K. Itoh Efficacy of Perflubutane Microbubble-Enhanced Ultrasound in the Characterization and Detection of Focal Liver Lesions: Phase 3 Multicenter Clinical Trial Am. J. Roentgenol., July 1, 2009; 193(1): 86 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Numata, M. Morimoto, T. Ogura, K. Sugimori, S. Takebayashi, M. Okada, and K. Tanaka Ablation Therapy Guided by Contrast-Enhanced Sonography with Sonazoid for Hepatocellular Carcinoma Lesions Not Detected by Conventional Sonography J. Ultrasound Med., March 1, 2008; 27(3): 395 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Maruyama, S Matsutani, H Saisho, Y Mine, N Kamiyama, T Hirata, and M Sasamata Real-time blood-pool images of contrast enhanced ultrasound with Definity in the detection of tumour nodules in the liver Br. J. Radiol., June 1, 2005; 78(930): 512 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Forsberg, W. T. Shi, C. R. B. Merritt, Q. Dai, M. Solcova, and B. B. Goldberg On the Usefulness of the Mechanical Index Displayed on Clinical Ultrasound Scanners for Predicting Contrast Microbubble Destruction J. Ultrasound Med., April 1, 2005; 24(4): 443 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Goldberg, D. A. Merton, J.-B. Liu, M. Thakur, G. F. Murphy, L. Needleman, A. Tornes, and F. Forsberg Sentinel Lymph Nodes in a Swine Model with Melanoma: Contrast-enhanced Lymphatic US Radiology, March 1, 2004; 230(3): 727 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Furuse, M Nagase, H Ishii, and M Yoshino Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions Br. J. Radiol., June 1, 2003; 76(906): 385 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Yang, G. M. K. Tse, P. K. W. Lam, C. Metreweli, and J. Chang Correlation Between Color Power Doppler Sonographic Measurement of Breast Tumor Vasculature and Immunohistochemical Analysis of Microvessel Density for the Quantitation of Angiogenesis J. Ultrasound Med., November 1, 2002; 21(11): 1227 - 1235. [Abstract] [Full Text] [PDF] |
||||